Introduction: What I Witnessed in Boston Changed How I See This Crisis
In October 2024, I stood before a room full of law enforcement leaders at the IACP conference in Boston. I was there to present data – cold, empirical, undeniable data about cardiovascular mortality in the tactical profession.
I have given this presentation many times. But something about that day stays with me.
Perhaps it was the silence in the room when I showed the numbers:
- Law enforcement officers live an average of 20 years less than the general population.
- The average age of a first heart attack among officers is 46.
Perhaps it was the Police Chief Paul Marzocca who approached me afterward. He had listened to every word, taken notes, and asked questions that told me he was already mentally rearranging his department’s priorities.
Or perhaps it was what happened next.
Mr Marzocca took the data back to his department and acted. He arranged for his entire team to undergo advanced cardiovascular screening through Sigma. The results?
62% of his officers tested positive for elevated Lp-PLA2 – a marker of high-risk vascular inflammation that no annual physical would have detected.
The Chief himself had an Lp-PLA2 of 170. Alarmingly high. Despite losing 70 pounds and working out daily, his genetics told a different story than his mirror.
He later wrote to me:
“As a Police Chief, it is now my mission to make sure my officers reach retirement and get to enjoy their lives and families. If I hadn’t attended that presentation, I would never have known. My family and I are grateful—Sigma made a difference.”
That letter sits with me every day.
Because here is the uncomfortable truth: most of what people believe about cholesterol is incomplete. And that incompleteness is costing lives.
The Chief’s story is not a feel-good anecdote. It is a window into a systemic failure. Standard medical protocols, designed for the general population, are missing the markers that matter most for tactical professionals under unique physiological stress.
This article is about five myths that perpetuate that failure and what we can do about it.
Myth #1: All Cholesterol Is Created Equal
The Truth: Cholesterol is a family of particles, and some are far more dangerous than others.
When most people hear “LDL,” they picture a single, uniform substance floating through their bloodstream. The reality is more complex.
LDL comes in different forms:
- Large, fluffy LDL – These particles float through your arteries with minimal trouble. They are less likely to cause harm.
- Small, dense LDL – These are the particles to watch. Their small size allows them to penetrate arterial walls more easily, where they oxidize and trigger the inflammatory cascade that leads to plaque formation.
Here is the twist that surprises most people: these dangerous small, dense LDL particles are driven largely by refined carbohydrates and sugar, not dietary fat. Excess processed carbs raise triglycerides and increase the liver’s production of small LDL.
The bottom line: It is not just how much LDL you have. It is what type. And for many people, the most harmful LDL is fueled more by sugar than steak.
Myth #2: “Normal” Cholesterol Means You’re Safe
The Truth: Heart attacks happen because of plaque and inflammation, not just cholesterol numbers.
The Police Chief from IACP had no idea he was at risk. He had lost 70 pounds. He worked out daily. By every conventional measure, he was doing everything right.
But his Lp-PLA2 – a marker of vascular inflammation told a different story.
Plaque can form long before labs look abnormal. Standard cholesterol panels measure lipids in the blood. They do not measure what is happening inside your arterial walls. By the time LDL numbers creep into the “high” range, atherosclerosis may have been developing for decades.
That is why comprehensive cardiovascular screening looks deeper:
- Coronary Calcium Score (CAC) – Directly visualizes and quantifies plaque in the coronary arteries
- Carotid Intima-Media Thickness (CIMT) – Detects the earliest structural changes in arterial walls
- oxLDL and Lp-PLA2 – Measures vascular inflammation, the kindling that ignites plaque rupture
If plaque or inflammation is present, treatment may be warranted even with “perfect” labs.
The bottom line: Numbers don’t tell the whole story. Plaque and inflammation guide real risk.
Myth #3: Cholesterol Is Just a Diet Problem
The Truth: Your liver produces 75–85% of your cholesterol. Genetics play a major role.
The Chief’s story illustrates this perfectly. After losing 70 pounds and working out daily, he assumed his risk had plummeted. It had for some things. But his Lp-PLA2 remained alarmingly high.
His own words capture the lesson: “I realize I can’t change genetics.”
Genetic factors drive cholesterol levels in ways diet alone cannot overcome:
- Familial Hypercholesterolemia – A genetic mutation that impairs the liver’s ability to remove LDL from the blood
- Elevated Lipoprotein(a) – A highly heritable, independent risk factor for heart disease that standard panels rarely measure
- High ApoB – A more precise measure of atherosclerotic particle count, often genetically influenced
Does diet matter? Absolutely, especially excess sugar and refined carbs, which drive the harmful small, dense LDL discussed earlier. But many patients cannot “eat their way” out of inherited risk.
The bottom line: Cholesterol is largely genetic. Diet can worsen it but it is often not the root cause.
Myth #4: Lipid Treatment Is Dangerous
The Truth: Statins are among the most studied drugs in medicine, with a well-established safety profile.
For years, the Chief had resisted his doctors’ recommendations to start a statin. Like many people, he had absorbed the fear-based narratives surrounding cholesterol medication.
His Lp-PLA2 of 170 changed his mind.
The data is clear:
- True statin intolerance (defined as the inability to tolerate any statin at any dose) affects less than 5% of patients. Most muscle aches attributed to statins are not actually caused by the medication.
- Serious liver injury from statins is extremely rare; far rarer than the liver damage caused by untreated obesity and fatty liver disease.
- Dementia risk? A comprehensive 2021 review in the Journal of the American College of Cardiology found no reliable evidence that statins impair cognition. In fact, by reducing vascular brain injury, they may protect cognitive function over the long term.
For appropriately selected patients, lipid-lowering therapy significantly reduces the risk of heart attack and stroke. The risk of not treating elevated cholesterol is far greater than the risk of treatment.
The bottom line: Fear of medication should not stand between patients and evidence-based prevention.
Myth #5: A Standard Lipid Panel Is Enough
The Truth: Standard testing is basic screening. Advanced testing provides precision prevention.
The Chief’s department discovered that 62% of personnel had elevated Lp-PLA2. A standard lipid panel would have missed every single one of them.
Most routine physicals include a standard lipid panel measuring:
- Total cholesterol
- LDL cholesterol
- HDL cholesterol
- Triglycerides
These numbers are helpful—they provide a snapshot. But a snapshot is not a comprehensive risk assessment.
Advanced lipid testing evaluates what standard panels miss:
- LDL particle size and number – Because small, dense LDL matters more than total LDL
- Lipoprotein(a) – An independent genetic risk factor
- IDL and VLDL – Intermediate and very low-density lipoproteins that contribute to plaque
- Inflammatory markers – oxLDL, Lp-PLA2, MPO, which reveal whether cholesterol is causing damage
The bottom line: Standard testing tells you that cholesterol exists. Advanced testing tells you whether that cholesterol is actually harming you.
How Sigma Tactical Wellness Changes the Equation
At Sigma Tactical Wellness, we built our entire approach around one uncomfortable truth:
standard protocols are not enough for the people who carry the heaviest load.
The Police Chief’s story is why we exist. His 62% positivity rate for Lp-PLA2 is not an outlier; it is a mirror held up to the law enforcement profession.
Here is what Sigma does differently:
- We Look Beneath the Surface
We do not stop at standard lipid panels. Our comprehensive screening includes coronary calcium scoring, carotid IMT, and advanced biomarkers like oxLDL and Lp-PLA2. We find plaque and inflammation before symptoms appear – just as we did for the Chief and his department.
- We Are Physician-Led, Not Algorithm-Driven
Every result is reviewed by a cardiologist or clinical experts. No generic reports. No automated advice. Just clinical judgment applied to real data.
- We Connect You to Care-Immediately
SIGMA 360 bridges the gap between detection and action. Participants receive direct, virtual access to expert cardiology care without delay. No waiting lists. No referral mazes. Just connection to the right specialist when risk is identified.
- We Built This for First Responders
Traditional healthcare systems are not designed for unpredictable shifts, operational stress, or the hidden cardiovascular burden of tactical professions. SIGMA 360 is: Our approach ensures:
- Fast access to specialized cardiovascular care
- Continuity of care from the moment risk is detected
- A full-circle health solution built specifically for those who serve
The Bottom Line
The Police Chief who walked into that IACP lecture in Boston had no idea he was leaving with a mission.
Today, he is alive. His officers are being screened. And his words capture why this work matters:
“For police chiefs, what matters more than being proactive, protecting your officers’ lives, and ensuring they receive the retirement they deserve?”
The myths surrounding cholesterol persist because they are comfortable. They tell us that normal labs mean we are safe. They tell us that diet alone controls our destiny. They tell us that standard testing is sufficient.
The data and the 62% of one department’s personnel with hidden inflammation says otherwise.
Your heart does not care about myths. It cares about what is happening inside your arteries.
If you are responsible for your own health or for the men and women who serve under your command; it is time to look deeper.
Learn More About Sigma’s Cardiovascular Screening